Application no. and date | 11764040.9 (espacenet) (Federated) (European Patent Register), 20110916 | Patent/reg. no. and date | DK/EP 2616090, 20230823 | Publication date | 20130724 | Priority no. and date | US 384209 P, 20100917 | EP pub. no. and date |
EP 2616090 20130724 | Effective date | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome Chuo-ku Osaka-shi
Osaka, JP | Applicant ref. no. | P83003DK01 | Inventor | TESCHNER, Wolfgang, Gestettengasse 19/14
A-1030 Wien, AT, SCHWARZ, Hans-Peter, Weimarer Strasse 76
A-1180 Wien, AT, BUTTERWECK, Harald, Arno, Naufahrtweg 5
A-1220 Wien, AT, KÖLBL, Bernhard, Hintausstrasse 20/5
2481 Achau, AT, GNAUER, Lucia, Ebersbrunn 38
3711 Ebersbrunn, AT | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 38/00 (2006.01) , A61K 38/48 (2006.01) , A61K 39/395 (2006.01) , A61K 47/02 (2006.01) , A61K 47/12 (2006.01) , A61K 47/18 (2017.01) , A61K 9/00 (2006.01) | Title | STABILISERING AF IMMUNOGLOBULINER GENNEM VANDIG FORMULERING MED HISTIDIN VED SVAG SYRE TIL NEUTRAL PH | Int. application no. | US2011052053 | Int. publication no. | WO2012037534 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|